Vector Space Biosciences announces it has begun filing for licensing and registration for the design, development and launching of biological CubeSats, enabling biotechnology, pharmaceutical and ...

Replicate Bioscience, a clinical-stage company pioneering next-generation self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic areas, ...

Vector Space Biosciences enables researchers in space biosciences, biotechnology and pharmaceutical development to capture changes in these relationships in real-time.

Vector Space Biosciences today announced it is developing large language modeling (LLMs) and visualization applications in collaboration with the Orac ...

Partnership to Bolster Solid Biosciences’ Gene Therapy Pipeline, Including AAV Process Development, Scale Up and cGMP Manufacturing Services Forge will provide an adeno-associated viral (AAV ...

SAN FRANCISCO, Calif., Nov. 29, 2021 /PRNewswire/ -- Vector Space Biosciences, parent company of Vectorspace AI, announces the following three additions to its Scientific Advisory Board (SAB ...

Vector Space Biosciences announces it has begun filing for licensing and registration for the design, development and launching of biological CubeSats ...